• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[替拉替尼治疗光化性角化病:1例病例的器械评估及长期随访描述。]

[Tirbanibulin in the treatment of actinic keratoses: description of a case with instrumental evaluation and long-term follow-up.].

作者信息

Lacarrubba Francesco, Verzì Anna Elisa, Dimarco Stefano, Luppino Ivano, dall'Oglio Federica, Micali Giuseppe

机构信息

Clinica Dermatologica, Università di Catania.

出版信息

Recenti Prog Med. 2024 Oct;115(10):37e-41e. doi: 10.1701/4357.43475.

DOI:10.1701/4357.43475
PMID:39446004
Abstract

A 72-year-old man presented with actinic keratosis (AK) of the scalp confirmed by line-field confocal optical coherence tomography (LC-OCT) a novel non-invasive skin imaging technique. Patient was treated with Tirbanibulin 1% ointment once a day for 5 consecutive days and, after 8 days from baseline, mild erythema and desquamation was observed on the treated area, associated with mild pruritus. At the same time-point, L'LC-OCT revealed the presence of intraepidermal "targeted-like" cells, corresponding to apoptotic keratinocytes. After 2 months, clinical and instrumental examination showed the almost total disappearance of the AK. At the same time-point, a strong improvement of photoaging was noted at the level of the treated area. At 1-year follow-up, no relapse and/or new AK were observed. In conclusion, the reported case is emblematic of the short and long-term efficacy and safety of tirbanibulin in the treatment of AK, as already reported in the literature, as well as of the usefulness of non-invasive imaging technique such as LC-OCT in the therapeutic monitoring.

摘要

一名72岁男性因头皮光化性角化病(AK)就诊,经线场共聚焦光学相干断层扫描(LC-OCT,一种新型非侵入性皮肤成像技术)确诊。患者接受1%替巴替尼软膏治疗,每天一次,连续5天,从基线起8天后,治疗区域出现轻度红斑和脱屑,并伴有轻度瘙痒。在同一时间点,LC-OCT显示存在表皮内“靶向样”细胞,对应凋亡的角质形成细胞。2个月后,临床和仪器检查显示AK几乎完全消失。在同一时间点,观察到治疗区域的光老化有明显改善。在1年随访中,未观察到复发和/或新的AK。总之,如文献中已报道的那样,该病例体现了替巴替尼治疗AK的短期和长期疗效及安全性,以及诸如LC-OCT等非侵入性成像技术在治疗监测中的有用性。

相似文献

1
[Tirbanibulin in the treatment of actinic keratoses: description of a case with instrumental evaluation and long-term follow-up.].[替拉替尼治疗光化性角化病:1例病例的器械评估及长期随访描述。]
Recenti Prog Med. 2024 Oct;115(10):37e-41e. doi: 10.1701/4357.43475.
2
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.他扎罗汀乳膏 1%治疗光化性角化病的疗效观察:Ⅰ期和Ⅱ期临床结果
J Drugs Dermatol. 2020 Nov 1;19(11):1093-1100. doi: 10.36849/JDD.2020.5576.
3
Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.替比嘧啶 1%软膏在光化性角化病中的疗效和安全性:来自两项 III 期临床试验和在 2022 年欧洲皮肤病学和性病学会大会上展示的真实临床实践的数据。
J Eur Acad Dermatol Venereol. 2024 Jan;38 Suppl 1:3-15. doi: 10.1111/jdv.19636.
4
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.三期临床试验研究替比嘧啶软膏治疗光化性角化病。
N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040.
5
Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.光学相干断层扫描与反射式共聚焦显微镜联合用于监测0.5% 5-氟尿嘧啶和10%水杨酸治疗临床及亚临床光化性角化病的效果
J Eur Acad Dermatol Venereol. 2016 Feb;30(2):258-65. doi: 10.1111/jdv.13445. Epub 2015 Nov 4.
6
Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis.反射共聚焦显微镜作为一种非侵入性工具,用于监测替比嘧啶在光化性角化病中的疗效。
Photodiagnosis Photodyn Ther. 2024 Aug;48:104235. doi: 10.1016/j.pdpdt.2024.104235. Epub 2024 Jun 6.
7
Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis.1%替比嘧啶软膏在光化性角化病受试者中的 1 期最大使用药代动力学研究。
Clin Pharmacol Drug Dev. 2022 Mar;11(3):397-405. doi: 10.1002/cpdd.1041. Epub 2021 Nov 16.
8
1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.1%替比嘧啶软膏治疗光化性角化病。
Ann Pharmacother. 2022 Apr;56(4):494-500. doi: 10.1177/10600280211031329. Epub 2021 Jul 23.
9
[Efficacy of topical tirbanibulin in treating actinic keratosis.].局部用替巴替尼治疗光化性角化病的疗效。
Recenti Prog Med. 2024 Oct;115(10):46e-47e. doi: 10.1701/4357.43477.
10
Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm of the face or scalp in patients with actinic keratosis: A phase 3 study.1%替巴尼布林软膏治疗光化性角化病患者面部或头皮100平方厘米区域的安全性和耐受性:一项3期研究。
JAAD Int. 2024 Jul 18;17:6-14. doi: 10.1016/j.jdin.2024.07.001. eCollection 2024 Dec.